Market Cap (In JPY)
4.24 Billion
Revenue (In JPY)
530 Thousand
Net Income (In JPY)
-933.41 Million
Avg. Volume
2.41 Million
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 111.0-325.0
- PE
- -
- EPS
- -
- Beta Value
- 0.772
- ISIN
- JP3802640007
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Toshimi Miyoshi Ph.D., Pharm.D.
- Employee Count
- -
- Website
- https://www.funpep.co.jp
- Ipo Date
- 2020-12-25
- Details
- FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides. The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis. It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis. FunPep Company Limited was incorporated in 2013 and is based in Tokyo, Japan.
More Stocks
-
KLM
-
CSGH
-
264900
-
ALBT
-
CYYNF
-
UAMY
-
SASOFSasol Limited
SASOF
-
1711